학술논문
Proteoglycan-4 is correlated with longer survival in HCC patients and enhances sorafenib and regorafenib effectiveness via CD44 in vitro
Document Type
Article
Author
Source
In: Cell Death and Disease . (Cell Death and Disease, November 2020, 11(11))
Subject
Language
English
ISSN
20414889